Your browser doesn't support javascript.
loading
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial.
Halliday, Brian P; Wassall, Rebecca; Lota, Amrit S; Khalique, Zohya; Gregson, John; Newsome, Simon; Jackson, Robert; Rahneva, Tsveta; Wage, Rick; Smith, Gillian; Venneri, Lucia; Tayal, Upasana; Auger, Dominique; Midwinter, William; Whiffin, Nicola; Rajani, Ronak; Dungu, Jason N; Pantazis, Antonis; Cook, Stuart A; Ware, James S; Baksi, A John; Pennell, Dudley J; Rosen, Stuart D; Cowie, Martin R; Cleland, John G F; Prasad, Sanjay K.
Afiliação
  • Halliday BP; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
  • Wassall R; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.
  • Lota AS; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
  • Khalique Z; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
  • Gregson J; London School of Hygiene & Tropical Medicine, London, UK.
  • Newsome S; London School of Hygiene & Tropical Medicine, London, UK.
  • Jackson R; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.
  • Rahneva T; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.
  • Wage R; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.
  • Smith G; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.
  • Venneri L; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.
  • Tayal U; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
  • Auger D; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.
  • Midwinter W; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
  • Whiffin N; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK; MRC London Institute of Medical Sciences, Imperial College London, London, UK.
  • Rajani R; Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
  • Dungu JN; Basildon and Thurrock Hospitals NHS Foundation Trust, Essex, UK.
  • Pantazis A; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.
  • Cook SA; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK; MRC London Institute of Medical Sciences, Imperial College London, London, UK; National Heart Centre Singapore, Sing
  • Ware JS; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK; MRC London Institute of Medical Sciences, Imperial College London, London, UK.
  • Baksi AJ; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
  • Pennell DJ; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
  • Rosen SD; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK; Department of Cardiology, Ealing Hospital, London, UK.
  • Cowie MR; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
  • Cleland JGF; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.
  • Prasad SK; Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK. Electronic address: s.prasad@rbht.nhs.uk.
Lancet ; 393(10166): 61-73, 2019 01 05.
Article em En | MEDLINE | ID: mdl-30429050
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cardiomiopatia Dilatada / Fármacos Cardiovasculares / Suspensão de Tratamento / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cardiomiopatia Dilatada / Fármacos Cardiovasculares / Suspensão de Tratamento / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido